![Martin Tolstrup](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Tolstrup
Corporate Officer/Principal bei Århus Universitetshospital
Profil
Martin Tolstrup is the founder of EnFutech ApS and iSD Immunotech ApS, both founded in 2007.
He is currently working as a Laboratory Head at Århus Universitetshospital.
Aktive Positionen von Martin Tolstrup
Unternehmen | Position | Beginn |
---|---|---|
Århus Universitetshospital
![]() Århus Universitetshospital Hospital/Nursing ManagementHealth Services Aarhus Universitetshospital is a highly specialized hospital located in Aarhus, DK. Aarhus Universitetshospital has been named Denmark's best hospital several times and is known for its specialized medical services. The hospital has subsidiaries in Denmark. The Danish company was founded in 2011, and Poul Blaabjerg has been the CEO of the company since 2017. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Martin Tolstrup
Unternehmen | Position | Ende |
---|---|---|
iSD Immunotech ApS
![]() iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Gründer | - |
EnFutech ApS
![]() EnFutech ApS BiotechnologyHealth Technology EnFutech ApS is a holding company that develops technologies for prevention, treatment, and eradication of Human Immunodeficiency Virus (HIV). Its platforms include both a new type of inhibitor that can be used as a prophylactic agent as well as a traditional drug for treatment of infection and a gene therapeutical approach to rendering the T-cells immune to HIV infection. The firm aims to combat infection, by developing effective anti-HIV treatments that can remove the virus both before and after it infects human cells. Its treatment is based on its novel technologies of blocking the HIV co-receptors using retargeted envelope proteins and receptor interference. The company was founded by Finn Skou Pedersen and Martin Tolstrup on August 23, 2007 and is headquartered in Aarhus, Denmark. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
EnFutech ApS
![]() EnFutech ApS BiotechnologyHealth Technology EnFutech ApS is a holding company that develops technologies for prevention, treatment, and eradication of Human Immunodeficiency Virus (HIV). Its platforms include both a new type of inhibitor that can be used as a prophylactic agent as well as a traditional drug for treatment of infection and a gene therapeutical approach to rendering the T-cells immune to HIV infection. The firm aims to combat infection, by developing effective anti-HIV treatments that can remove the virus both before and after it infects human cells. Its treatment is based on its novel technologies of blocking the HIV co-receptors using retargeted envelope proteins and receptor interference. The company was founded by Finn Skou Pedersen and Martin Tolstrup on August 23, 2007 and is headquartered in Aarhus, Denmark. | Health Technology |
iSD Immunotech ApS
![]() iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Health Technology |
Århus Universitetshospital
![]() Århus Universitetshospital Hospital/Nursing ManagementHealth Services Aarhus Universitetshospital is a highly specialized hospital located in Aarhus, DK. Aarhus Universitetshospital has been named Denmark's best hospital several times and is known for its specialized medical services. The hospital has subsidiaries in Denmark. The Danish company was founded in 2011, and Poul Blaabjerg has been the CEO of the company since 2017. | Health Services |